To evaluate the mortality rates for prostate cancer according to geographical areas in Peru between 2005 and 2014.
Introduction
Prostate cancer is the second most frequently diagnosed neoplasm in men and the fifth cause of cancer death worldwide [1] [2] [3] . In 2012, it represented 15% of all new cases of cancer diagnosed in men [1] , and in 2013, it caused 4.8 million disability-adjusted life years worldwide, of which 43% were in low-and middle-income countries (LMICs) [4] .
For most LMICs, data collection related to incidence and mortality for prostate cancer has limited validity [5] . In order to understand these patterns in Latin America, we conducted a literature search [6] regarding prostate cancer in the region. Between 2005 and 2009, mortality rates for Cuba were of 23.6 per 100 000 men, and between 2007 and 2009, Uruguay and Venezuela reported >18 deaths per 100 000 men. Overall, Latin America prostate cancer mortality at all ages has tended to increase [7] .
In Peru, the incidence rates for prostate cancer were high in specific areas (Lima and Arequipa with 48.4 and 32.1 per 100 000 population, respectively) [8] . Moreover, for Metropolitan Lima, it was reported that the age-standardised mortality rate (ASMR) for prostate cancer increased from 11.4 (2004-2005) to 15.7 (2010-2012) per 100 000 population [9, 10] . There are still no recent epidemiological studies focusing solely on prostate cancer in Peru and analysing it by regions.
The objective of the present study was to provide the first epidemiological evidence for the mortality rates from prostate cancer in Peruvian men between 2005 and 2014, according to geographical location.
Materials and Methods

Design and Study Setting
We conducted a secondary data analysis using the Peruvian Ministry of Health's database regarding prostate cancer deaths (code C61 according to the International Classification of Diseases, 10th revision) [11] between 2005 and 2014.
These registries are based on the reports from hospitals that are distributed throughout the country and most of which are part of the health network of the Ministry of Health. Although they do not include information from other sources (such as social security insurance or private insurances), they collect information on cancers in all provinces from the main provider of healthcare service (70%) [12] . The cancer reporting system is limited by the scarcity of staff in public hospitals, high staff turnover, and the lack of supervision of data quality. These factors yield problems in data accuracy and completeness. For this reason, the calculation was made taking into consideration an under reporting of 40% estimated by the Peruvian Ministry of Health [13] .
Peru is composed of 25 provinces, distributed in three geographical regions: coast, highlands, and rainforest [14, 15] . The coast has experienced significant and unplanned population growth in urbanised areas in low-altitude settings; the highlands are a high-altitude area, with both urban and rural populations; and the rainforest is located throughout the Peruvian Amazon [14, 15] (Fig. 1 [16] ).
Statistical and Spatial Analysis
We used the number of prostate cancer deaths and population data to calculate the ASMR.
We calculated region-specific mortality rates for each 5-year age group and calendar period and derived ASMR by the direct method, using the world standard population [17] . We estimated mortality rates per 100 000 men. As the denominator, we used the population in 5-year age groups, provided by the National Statistics Institute [16] . We used R software (version R 3.4.1; R Foundation for Statistical Computing, Vienna, Austria) for the statistical analysis [18] .
We used the GeoDA TM (Luc Anselin, Spatial Analysis Laboratory, Department of Agricultural and Consumer Economics, University of Illinois, Urbana-Champaign, Urbana, IL, USA) software package for the spatial analysis [19] . We mapped the spatial distribution of prostate cancer mortality rates to determine whether geographical groups were evident. The spatial analysis was performed using (Table 1) . Analysing by regions, the coastal region had the highest mortality with a range of 22.3-29.0 per 100 000 men when compared to the regions of the highlands (11.8-17.1 per 100 000 men) and rainforest (4.0-11.6 per 100 000 men) (Fig. 2) . Prostate cancer mortality rates increased by 16% and 15.6% in the coastal and the highlands regions, respectively. In contrast, the mortality rates for the rainforest region decreased by 18.7%. (Table 1) . The provinces with the highest mortality were Piura, Lambayeque, La Libertad, Callao, Lima, Ica, and Arequipa (Fig. 3 According to the National Household Survey,~30% of the Peruvian population still does not have health insurance [20, 21] . The Peruvian health system is poorly organised with many disparities existing between healthcare providers' systems [12] . Preventive health policies have not been properly adopted by the Ministry of Health (there is no national screening programme, no DRE and no PSA level testing for prostate cancer) [22] . According to regions, the highest mortality rates were seen in the coastal region (mainly in the provinces of Piura, Lambayeque, La Libertad, Callao, Lima, Ica, and Arequipa) when compared to the highlands and the rainforest. This could be related to deficient reporting systems in the highlands and rainforest, as these areas are less developed with less accessible healthcare; however, the rates for both regions follow an ascending (highlands) and descending (rainforest) pattern over the years. Other explanations could be ethnic and racial differences, age, and overweight/obesity status in the coastal region. Regarding race, Black men show a higher prostate cancer mortality rate [23] , even when adjusting for other cofactors such as education and income levels [24, 25] . Even though Peru has a high degree of racial mixing, the coastal region has a strong African influence [26] , which may explain those high rates. In addition, the risk of prostate cancer also increases with age [27, 28] , and >70% of men have histological evidence of prostate cancer by the time they are aged 80 years [17] . Currently, elderly adults represent 10% of the Peruvian population [18] and there is a larger proportion of men aged >65 years in the coastal region (9%) compared to the other two regions (the highlands and the rainforest with~7%) [10] . Another risk factor is overweight/obesity [27, 29] , which is associated with an increased risk of mortality and recurrence from prostate cancer [30] . As the coastal region shows the highest obesity rates in adults [31] and children [15] , this could also explain their higher mortality rate.
The coastal region has the main centres in oncology and the largest number of oncology trained professionals, mainly in the area of Lima [8] , including new cancer centres in the areas of La Libertad and Arequipa, which aim to help in the decentralisation of cancer care [32] . However, this is not sufficient as most patients are diagnosed with advanced stages, leading to a poor prognosis [22, 33] . Moreover, this region is considered the most densely populated with more than a third of the Peruvian population [34] demonstrates a directly proportional relationship with the burden of prostate cancer [36] .
Regarding spatial analysis and clustering, the areas in northeastern Peru (Loreto, Ucayali, and Madre de Dios) showed significantly lower mortality rates compared to their neighbouring areas. However, some areas, such as Madre de Dios, have increased their mortality in recent years.
Due to the lack of adequate services for the diagnosis and treatment of cancer, Peru is currently in the process of creating new cancer centres in the coastal and rainforest regions [32, 37] , in addition to establishing oncology units in general hospitals. The goal is to decrease mortality from prostate cancer and other neoplasms amongst Peruvians in the future. However, we would like to recommend the addition of more professionals trained in oncology, especially in the regions of the highlands and rainforest. Additionally, a comprehensive approach is needed to reduce the disparities in access to cancer care, as well as the modification of the risk factors related to mortality for prostate cancer.
The present study has limitations related to the use of secondary sources of information, including the possibility of having incorrect or incomplete data. Likewise, the data obtained and analysed in the present study did not allow us to compare by ethnicity or socioeconomic status, which would have provided a clearer overview about the risk from prostate cancer in Peruvian men. Nevertheless, this is the first effort to contribute to the literature on geographical differences in prostate cancer mortality in Peru. This information should help in the creation of health policies aimed at the population at risk and in improvement of data collection systems.
In conclusion, mortality rates from prostate cancer in Peru are still increasing. The mortality rates were higher in the coastal region. Conversely, they were lower in the highlands and rainforest. These related geographical differences in mortality could be a reflection of race/genetics and other well-established and modifiable risk factors, including obesity, the lack of a decentralised health system, and disparities in access to cancer care and incomplete reporting between regions. They may also reflect different validity of diagnosis and registration, which are difficult to evaluate, but are unlikely to totally explain the observed large variation in mortality rates.
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